MYH11延长突变导致巨膀胱-小结肠-肠蠕动不良综合征1例报告及文献复习

doi:10.12372/jcp.2024.24e0263

Abstract

Abstract:

Objective To report the clinical characteristics and genetic variant of a patient with megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) and to investigate the genotypic-phenotypic correlation through literatures review. Methods The clinical data of a MMIHS child who came to our hospital in October 2023 due to "repeated abdominal distension and vomiting for more than 3 years" were analyzed. Peripheral blood samples were collected from the patient, his parents and his older sister, and the pathogenic mutation was screened by Trio-WES and Sanger sequencing. Relevant literature was summarized and analyzed. Results The patient, a 15-year-old boy, presented with recurrent episodes of abdominal distension, vomiting, and abdominal pain. Abdominal X-ray and upper gastrointestinal contrast study indicated intestinal obstruction. The condition stabilized after treatment with enema, anti-infection and intravenous nutritional support. Genetic testing revealed a heterozygous mutation in the MYH11 gene, identified as c.5819delC (p.Pro1940Hisfs*91), which resulted in the extension of the C-end of the myosin heavy chain and was not detected by either parent or sister. A total of 7 articles related to MYH11 gene mutation were included in the literature review. Mutation types included missense mutations, frameshift mutations, and chromosomal microdeletion. Gender was undetermined in 2 out of 20 patients due to early termination of pregnancy. Among the remaining patients, the male-to-female ratio was 2:1. Genotypic-phenotypic correlation analysis found that 15 patients with dominant heterozygous protein‐elongating MYH11 variants were aged 9 (0-28) years at onset, and no deaths were reported. Five patients with recessive loss-of-function mutations had an onset age of less than 1 year, with 4 deaths (80%). Conclusion This MMIHS patient carries the MYH11 gene c.5819delC (p. Pro1940Hisfs*91) mutation. Compared with patients with MYH11 gene mutation recessive inheritance, those with dominant MYH11 mutations tend to have a later onset, milder clinical manifestations, and a higher survival rate.

Key words: megacystis-microcolon-intestinal hypoperistalsis syndrome, MYH11 gene, child

ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review[J].Journal of Clinical Pediatrics, 2024, 42(9): 798-804.

Figures/Tables 6

References 29

[1]	Hashmi SK, Ceron RH, Heuckeroth RO. Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton[J]. Am J Physiol Gastrointest Liver Physiol, 2021, 320(6): G919-G935.
[2]	Fournier N, Fabre A. Smooth muscle motility disorder phenotypes: a systematic review of cases associated with seven pathogenic genes (ACTG2, MYH11, FLNA, MYLK, RAD21, MYL9 and LMOD1)[J]. Intractable Rare Dis Res, 2022, 11(3): 113-119.
[3]	Halim D, Wilson MP, Oliver D, et al. Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice[J]. Proc Natl Acad Sci U S A, 2017, 114(13): E2739-E2747.
[4]	Halim D, Brosens E, Muller F, et al. Loss-of-function variants in MYLK cause recessive megacystis microcolon intestinal hypoperistalsis syndrome[J]. Am J Hum Genet, 2017, 101(1): 123-129. doi: S0002-9297(17)30198-2 pmid: 28602422
[5]	Moreno CA, Sobreira N, Pugh E, et al. Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome[J]. Europ J Hum Genet, 2018, 26(5): 669-675.
[6]	Li N, Song YM, Zhang XD, et al. Pseudoileus caused by primary visceral myopathy in a Han Chinese patient with a rare MYH11 mutation: a case report[J]. World J Clin Cases, 2022, 10(34): 12623-12630.
[7]	Frismantiene A, Philippova M, Erne P, et al. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity[J]. Cell Signal, 2018, 52: 48-64. doi: S0898-6568(18)30203-1 pmid: 30172025
[8]	Babu GJ, Warshaw DM, Periasamy M. Smooth muscle myosin heavy chain isoforms and their role in muscle physiology[J]. Microsc Res Tech, 2000, 50(6): 532-540.
[9]	Li M, Li S, Rao Y et al. Loss of smooth muscle myosin heavy chain results in the bladder and stomach developing lesion during foetal development in mice[J]. J Genet, 2018, 97(2): 469-475. pmid: 29932067
[10]	Milewicz DM, Trybus KM, Guo DC, et al. Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections[J]. Arterioscler Thromb Vasc Biol, 2017, 37(1): 26-34. doi: 10.1161/ATVBAHA.116.303229 pmid: 27879251
[11]	Gilbert MA, Schultz-Rogers L, Rajagopalan R, et al. Protein-elongating mutations in MYH11 are implicated in a dominantly inherited smooth muscle dysmotility syndrome with severe esophageal, gastric, and intestinal disease[J]. Hum Mutat, 2020, 41(5): 973-982.
[12]	Dong W, Baldwin C, Choi J, et al. Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing[J]. Clin Genet, 2019, 96(5): 473-477.
[13]	Wang Q, Zhang J, Wang H, et al. Compound heterozygous variants in MYH11 underlie autosomal recessive megacystis-microcolon-intestinal hypoperistalsis syndrome in a Chinese family[J]. J Hum Genet, 2019, 64(11): 1067-1073. doi: 10.1038/s10038-019-0651-z pmid: 31427716
[14]	Kloth K, Renner S, Burmester G, et al. 16p13.11 microdeletion uncovers loss-of-function of a MYH11 missense variant in a patient with megacystis-microcolon-intestinal-hypoperistalsis syndrome[J]. Clin Genet, 2019, 96(1): 85-90. doi: 10.1111/cge.13557 pmid: 31044419
[15]	Yetman AT, Starr LJ. Newly described recessive MYH11 disorder with clinical overlap of multisystemic smooth muscle dysfunction and megacystis microcolon hypoperistalsis syndromes[J]. Am J Med Genet A, 2018, 176(4): 1011-1014. doi: 10.1002/ajmg.a.38647 pmid: 29575632
[16]	Gauthier J, Ouled Amar Bencheikh B, Hamdan FF, et al. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome[J]. Europ J Hum Genet, 2015, 23(9): 1266-1268.
[17]	Thapar N, Saliakellis E, Benninga MA, et al. Paediatric intestinal pseudo-obstruction: evidence and consensus-based recommendations from an ESPGHAN-led expert group[J]. J Pediatr Gastroenterol Nutr, 2018, 66(6): 991-1019.
[18]	Fontanella F, Maggio L, Verheij JBGM, et al. Fetal megacystis: a lot more than LUTO[J]. Ultrasound Obstet Gynecol, 2019, 53(6): 779-787. doi: 10.1002/uog.19182 pmid: 30043466
[19]	Geraghty RM, Orr S, Olinger E, et al. Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome[J]. J Rare Dis (Berlin), 2023, 2(1): 9. doi: 10.1007/s44162-023-00012-z pmid: 37288276
[20]	Buinoiu N, Panaitescu A, Demetrian M, et al. Ultrasound prenatal diagnosis of typical megacystis, microcolon, intestinal hypoperistalsis syndrome[J]. Clin Case Rep, 2018, 6(5): 855-858.
[21]	Rosenblatt J, Dreux S, Spaggiari E, et al. Prenatal diagnosis of megacystis microcolon intestinal hypoperistalsis syndrome by biochemical analysis of fetal urine[J]. Prenatal Diagn, 2018. doi: 10.1002/pd.5283.
[22]	Di Nardo G, Zenzeri L, Guarino M, et al. Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction[J]. Expert Rev Gastroenterol Hepatol, 2023, 17(4): 325-341.
[23]	Viti F, De Giorgio R, Ceccherini I, et al. Multi-disciplinary Insights from the first European forum on visceral myopathy 2022 meeting[J]. Dig Dis Sci, 2023, 68(10): 3857-3871.
[24]	Kim SJ, Lee S, Park HJ, et al. Genetic association of MYH genes with hereditary hearing loss in Korea[J]. Gene, 2016, 591(1): 177-182.
[25]	Kocoshis SA, Goldschmidt ML, Nathan JD, et al. Esophageal dysmotility: an intrinsic feature of megacystis, microcolon, hypoperistalsis syndrome (MMIHS)[J]. J Pediatr Surg, 2019, 54(7): 1303-1307. doi: S0022-3468(18)30558-X pmid: 30257810
[26]	Kapur RP. Histopathological, ultrastructural, and immunohistochemical findings in MYH11-variant visceral myopathy[J]. Pediatr Dev Pathol, 2023, 26(1): 39-51.
[27]	Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus[J]. Nat Genet, 2006, 38(3): 343-349. doi: 10.1038/ng1721 pmid: 16444274
[28]	Chi M, Zhou Y, Vedamoorthyrao S, et al. Ablation of smooth muscle myosin heavy chain SM2 increases smooth muscle contraction and results in postnatal death in mice[J]. Proc Natl Acad Sci U S A, 2008, 105(47): 18614-18618.
[29]	Kuang SQ, Kwartler CS, Byanova KL, et al. Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells[J]. Circul Res, 2012, 110(11): 1411-1422.

病例	性别	发病年龄	消化系统症状	泌尿系统症状	其他	结局	文献
1	男	0	小结肠、便秘	巨膀胱、尿潴留	羊水少	死亡	[16]
2	男	0	小结肠	巨膀胱、肾盂扩张、输尿管扩张	瞳孔扩大、羊水少、感音神经性听力损失、肺动脉高压、主动脉扩张	死亡	[15]
3-1	－	0	－	巨膀胱	羊水少	终止妊娠	[13]
3-2	－	0	－	巨膀胱	羊水少	终止妊娠	[13]
4	女	0	小结肠	巨膀胱	生长激素缺乏、甲状腺功能减退、瞳孔扩大	存活	[14]
5	女	0	假性肠梗阻、回肠扭转、肛门括约肌张力低下	－	－	存活	[11]
6-1	男	11岁	食管裂孔疝	－	－	存活	[11]
6-2	男	7岁	食管裂孔疝、食道狭窄	－	－	存活
6-3	男	12岁	食管裂孔疝、食道狭窄	－	－	存活
6-4	女	4岁	食管裂孔疝、结肠动力障碍、十二指肠扩张	－	－	存活
6-5	女	4岁	食管裂孔疝、食道狭窄、十二指肠、空肠动力异常、坏死性小肠结肠炎	－	－	存活
7	男	12岁	假性肠梗阻	肾积水、尿路感染	－	存活	本文

病例	DNA	蛋白	突变类型	遗传方式	文献
1	c.3598A>T	p.Lys1200Ter	纯合错义突变	AR	[16]
2	c.2809_2810del；c.3422_3470del	p.Arg937Glyfs7；p.Lys1141Thrfs20	复合杂合突变	AR	[15]
3	c.2051G>A；c.3540_3541delinsTT	p.R684H ；p.（E1180D, Q1181Ter）	复合杂合突变	AR	[13]
4	c.379C>T；16p13.11 中1.3 Mb微缺失	p.Pro127Ser	复合杂合突变	AR	[14]
5	c.5819delC	p.Pro1940Hisfs*91	杂合延长突变	AD	[11]
6	c.5819_5820insCA	p.Gln1941Asnfs*91	杂合延长突变	AD	[11]
7	c.5819delC	p.Pro1940Hisfs*91	杂合延长突变	AD	本文
8	c.5819delC	p.Pro1940HisfsTer91	杂合延长突变	AD	[12]
9	c.5819delC	p.Pro1940Hisfs*91	杂合延长突变	AD	[6]

Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 29

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28.
[2]	LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34.
[3]	ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55.
[4]	JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13.
[5]	QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752.
[6]	FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773.
[7]	JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790.
[8]	CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816.
[9]	DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672.
[10]	LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677.
[11]	HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683.
[12]	WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690.
[13]	MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703.
[14]	WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727.
[15]	HUANG Shiyu, WANG Wei, ZHU Diqi, SHEN Jie, CAO Qing. Treatment and reflection of infective endocarditis caused by methicillin-resistant Staphylococcus aureus in children after complex congenital heart disease [J]. Journal of Clinical Pediatrics, 2024, 42(8): 728-736.